192 related articles for article (PubMed ID: 24991785)
1. Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease.
Kariyawasam VC; Selinger CP; Katelaris PH; Jones DB; McDonald C; Barr G; Chapman G; Colliwshaw J; Lunney PC; Middleton K; Wang RR; Huang T; Andrews J; Leong RW
Inflamm Bowel Dis; 2014 Aug; 20(8):1382-90. PubMed ID: 24991785
[TBL] [Abstract][Full Text] [Related]
2. Thiopurines prevented surgical recurrence in patients with Crohn's disease after intestinal resection: Strategy based on risk stratification.
Guo J; Chen BL; Chen ZH; Luo XP; Qiu Y; Zhang SH; Feng R; He Y; Zeng ZR; Song XM; Ben-Horin S; Mao R; Chen MH
J Gastroenterol Hepatol; 2018 Mar; 33(3):608-614. PubMed ID: 28804920
[TBL] [Abstract][Full Text] [Related]
3. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
González-Lama Y; Suárez C; González-Partida I; Calvo M; Matallana V; de la Revilla J; Magaz M; Bernardo C; Agudo B; Ibarrola P; Relea L; Arévalo J; Vera MI; Abreu L
J Crohns Colitis; 2016 Jan; 10(1):55-60. PubMed ID: 26520164
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic features of Crohn's disease associated with failure of medical treatment.
Moran GW; Dubeau MF; Kaplan GG; Yang H; Seow CH; Fedorak RN; Dieleman LA; Barkema HW; Ghosh S; Panaccione R;
Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351
[TBL] [Abstract][Full Text] [Related]
5. Thiopurines are associated with a reduction in surgical re-resections in patients with Crohn's disease: a long-term follow-up study in a regional and academic cohort.
van Loo ES; Vosseberg NW; van der Heide F; Pierie JP; van der Linde K; Ploeg RJ; Dijkstra G; Nieuwenhuijs VB
Inflamm Bowel Dis; 2013 Dec; 19(13):2801-8. PubMed ID: 24189041
[TBL] [Abstract][Full Text] [Related]
6. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
Walters TD; Kim MO; Denson LA; Griffiths AM; Dubinsky M; Markowitz J; Baldassano R; Crandall W; Rosh J; Pfefferkorn M; Otley A; Heyman MB; LeLeiko N; Baker S; Guthery SL; Evans J; Ziring D; Kellermayer R; Stephens M; Mack D; Oliva-Hemker M; Patel AS; Kirschner B; Moulton D; Cohen S; Kim S; Liu C; Essers J; Kugathasan S; Hyams JS;
Gastroenterology; 2014 Feb; 146(2):383-91. PubMed ID: 24162032
[TBL] [Abstract][Full Text] [Related]
7. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial.
Mowat C; Arnott I; Cahill A; Smith M; Ahmad T; Subramanian S; Travis S; Morris J; Hamlin J; Dhar A; Nwokolo C; Edwards C; Creed T; Bloom S; Yousif M; Thomas L; Campbell S; Lewis SJ; Sebastian S; Sen S; Lal S; Hawkey C; Murray C; Cummings F; Goh J; Lindsay JO; Arebi N; Potts L; McKinley AJ; Thomson JM; Todd JA; Collie M; Dunlop MG; Mowat A; Gaya DR; Winter J; Naismith GD; Ennis H; Keerie C; Lewis S; Prescott RJ; Kennedy NA; Satsangi J;
Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):273-282. PubMed ID: 28404197
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of response of perianal Crohn's disease to azathioprine or 6-mercaptopurine.
Lecomte T; Contou JF; Beaugerie L; Carbonnel F; Cattan S; Gendre JP; Cosnes J
Dis Colon Rectum; 2003 Nov; 46(11):1469-75. PubMed ID: 14605564
[TBL] [Abstract][Full Text] [Related]
9. Long-term prognosis of crohn's disease and its temporal change between 1981 and 2012: a hospital-based cohort study from Korea.
Park SH; Yang SK; Park SK; Kim JW; Yang DH; Jung KW; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
Inflamm Bowel Dis; 2014 Mar; 20(3):488-94. PubMed ID: 24412992
[TBL] [Abstract][Full Text] [Related]
10. Major Abdominal and Perianal Surgery in Crohn's Disease: Long-term Follow-up of Australian Patients With Crohn's Disease.
Toh JWT; Wang N; Young CJ; Rickard MJFX; Keshava A; Stewart P; Kariyawasam V; Leong R;
Dis Colon Rectum; 2018 Jan; 61(1):67-76. PubMed ID: 29215479
[TBL] [Abstract][Full Text] [Related]
11. Impact of timing and duration of thiopurine treatment on first perianal surgery in Crohn's disease: UK population-based study (1995-2009).
Chhaya V; Saxena S; Cecil E; Subramanian V; Curcin V; Majeed A; Pollok RC
Inflamm Bowel Dis; 2015 Feb; 21(2):385-91. PubMed ID: 25569740
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease.
Afzali A; Park CJ; Zhu K; Hu JK; Sharma P; Sinanan MN; Lee SD
Inflamm Bowel Dis; 2016 Aug; 22(8):1887-95. PubMed ID: 27057681
[TBL] [Abstract][Full Text] [Related]
13. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.
Lakatos PL; Golovics PA; David G; Pandur T; Erdelyi Z; Horvath A; Mester G; Balogh M; Szipocs I; Molnar C; Komaromi E; Veres G; Lovasz BD; Szathmari M; Kiss LS; Lakatos L
Am J Gastroenterol; 2012 Apr; 107(4):579-88. PubMed ID: 22233693
[TBL] [Abstract][Full Text] [Related]
14. Prolonged azathioprine treatment reduces the need for surgery in early Crohn's disease.
Qiu Y; Chen BL; Feng R; Zhang SH; He Y; Zeng ZR; Ben-Horin S; Peyrin-Biroulet L; Mao R; Chen MH
J Gastroenterol Hepatol; 2018 Mar; 33(3):664-670. PubMed ID: 28940780
[TBL] [Abstract][Full Text] [Related]
15. The impact of timing and duration of thiopurine treatment on first intestinal resection in Crohn's disease: national UK population-based study 1989-2010.
Chatu S; Saxena S; Subramanian V; Curcin V; Yadegarfar G; Gunn L; Majeed A; Pollok RC
Am J Gastroenterol; 2014 Mar; 109(3):409-16. PubMed ID: 24469612
[TBL] [Abstract][Full Text] [Related]
16. Predictors of immunomodulator use as early therapy in pediatric Crohn's disease.
Jacobstein DA; Mamula P; Markowitz JE; Leonard M; Baldassano RN
J Clin Gastroenterol; 2006 Feb; 40(2):145-8. PubMed ID: 16394876
[TBL] [Abstract][Full Text] [Related]
17. Thiopurine effectiveness in patients with Crohn's disease: a study of genetic and clinical predictive factors.
Koifman E; Karban A; Mazor Y; Chermesh I; Waterman M; Almog R; Ben-Horin S; Eliakim R; Krivoy N; Efrati E; Chowers Y
Inflamm Bowel Dis; 2013 Jul; 19(8):1639-44. PubMed ID: 23669401
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study.
Huang Z; Chao K; Li M; Zhi M; Tang J; Hu P; Gao X
Inflamm Bowel Dis; 2017 Mar; 23(3):440-447. PubMed ID: 28129286
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic role of methotrexate in pediatric Crohn's disease.
Djurić Z; Šaranac L; Budić I; Pavlović V; Djordjević J
Bosn J Basic Med Sci; 2018 Aug; 18(3):211-216. PubMed ID: 29338679
[TBL] [Abstract][Full Text] [Related]
20. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
